Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 112

1.
2.

[Comparison of benefits to non-dialysis CKD patients between darbepoetin alpha and epoetin beta pegol].

Ito C, Akimoto T, Morishita Y, Yamamoto H, Ogura M, Yamazaki T, Miki A, Homma S, Kusano E, Asano Y, Nagata D.

Nihon Jinzo Gakkai Shi. 2015;57(7):1233-40. Japanese.

PMID:
26665615
3.

Evaluation of clinical and laboratory variables associated with anemia in pediatric patients on hemodialysis.

Freitas JS, Costa PS, Costa LR, Naghettini AV.

J Pediatr (Rio J). 2015 Jan-Feb;91(1):87-92. doi: 10.1016/j.jped.2014.05.009.

4.

Anaemia management in patients with chronic kidney disease: Taiwan practice guidelines.

Hung SC, Kuo KL, Tarng DC, Hsu CC, Wu MS, Huang TP.

Nephrology (Carlton). 2014 Dec;19(12):735-9. doi: 10.1111/nep.12332. Review.

PMID:
25156587
5.

The relationship of Prohepcidin levels with anemia and inflammatory markers in non-diabetic uremic patients: a controlled study.

Aydin Z, Gursu M, Karadag S, Uzun S, Sumnu A, Doventas Y, Ozturk S, Kazancioglu R.

Ren Fail. 2014 Sep;36(8):1253-7. doi: 10.3109/0886022X.2014.937663.

PMID:
25040737
6.

Iron status and benefit of the use of parenteral iron therapy in pre-dialysis Chronic Kidney disease patients.

Arogundade FA, Soyinka FO, Sanusi AA, Ojo OE, Akinsola A.

Niger Postgrad Med J. 2013 Dec;20(4):299-304.

PMID:
24633272
7.

[Diastolic dysfunction in different types of left ventricular hypertrophy in patients with end-stage renal failure: impact of long-term erythropoietin therapy].

Dzgoeva FU, Gatagonova TM, Kadzaeva ZK, Khamitsaeva OV, Kochisova ZKh, Dzueva AT, Bazaeva BG, Bestaeva TL.

Ter Arkh. 2013;85(6):44-50. Russian.

PMID:
23866598
8.

Impact of inflammation on anemia of hemodialysis patients who were under treatment of recombinant human erythropoietin.

Rafiean-Kopaie M, Nasri H.

J Renal Inj Prev. 2013 Sep 1;2(3):93-5. doi: 10.12861/jrip.2013.30.

9.

[Multi-frequency low-dose intravenous iron on oxidative stress in maintenance hemodialysis patients].

Yin L, Chen X, Chen J, Cheng M, Peng Y, Yang L.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012 Aug;37(8):844-8. doi: 10.3969/j.issn.1672-7347.2012.08.015. Chinese.

10.

Total allowable concentrations of monomeric inorganic aluminum and hydrated aluminum silicates in drinking water.

Willhite CC, Ball GL, McLellan CJ.

Crit Rev Toxicol. 2012 May;42(5):358-442. doi: 10.3109/10408444.2012.674101. Review.

PMID:
22512666
11.

Analytical and biological variation in measures of anemia and iron status in patients treated with maintenance hemodialysis.

Van Wyck DB, Alcorn H Jr, Gupta R.

Am J Kidney Dis. 2010 Sep;56(3):540-6. doi: 10.1053/j.ajkd.2010.05.009.

PMID:
20638166
12.

[Characteristics of anaemia treatment in children with chronic kidney disease].

Puretić Z.

Acta Med Croatica. 2009 Sep;63 Suppl 1:27-32. Croatian.

PMID:
20235352
13.

Comparative mortality risk of anemia management practices in incident hemodialysis patients.

Brookhart MA, Schneeweiss S, Avorn J, Bradbury BD, Liu J, Winkelmayer WC.

JAMA. 2010 Mar 3;303(9):857-64. doi: 10.1001/jama.2010.206.

PMID:
20197532
14.

Influence of erythropoietin therapy on serum prohepcidin levels in dialysis patients.

Arabul M, Gullulu M, Yilmaz Y, Eren MA, Baran B, Gul CB, Kocamaz G, Dilek K.

Med Sci Monit. 2009 Nov;15(11):CR583-7.

PMID:
19865058
15.

Effect of hepatitis C virus on hemoglobin and hematocrit levels in saudi hemodialysis patients.

Alsaran KA, Sabry AA, Alghareeb AH, Al Sadoon G.

Ren Fail. 2009;31(5):349-54.

PMID:
19839833
16.

Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial).

Barraclough KA, Noble E, Leary D, Brown F, Hawley CM, Campbell SB, Isbel NM, Mudge DW, van Eps CL, Sturtevant JM, Johnson DW.

BMC Nephrol. 2009 Jul 28;10:20. doi: 10.1186/1471-2369-10-20.

17.

[Intravenous iron sucrose in maintenance dialysis patients with renal anemia: a clinical study].

Li H, Wang SX.

Zhonghua Yi Xue Za Zhi. 2009 Feb 24;89(7):457-62. Chinese.

PMID:
19567093
18.

The effect of nutritional status, body composition, inflammation and serum iron on the developement of insulin resistance among patients on long-term hemodialysis.

Rasić-Milutinović Z, Perunicić G, Pljesa S, Gluvić Z, Ilić M, Stokić E.

Med Pregl. 2007;60 Suppl 2:33-8.

PMID:
18928154
19.
20.

Serum ferritin level remains a reliable marker of bone marrow iron stores evaluated by histomorphometry in hemodialysis patients.

Rocha LA, Barreto DV, Barreto FC, Dias CB, Moysés R, Silva MR, Moura LA, Draibe SA, Jorgetti V, Carvalho AB, Canziani ME.

Clin J Am Soc Nephrol. 2009 Jan;4(1):105-9. doi: 10.2215/CJN.01630408.

Supplemental Content

Loading ...
Support Center